Mar Vista Investment Partners LLC Reduces Stake in Danaher Corporation $DHR

Mar Vista Investment Partners LLC lowered its position in shares of Danaher Corporation (NYSE:DHR) by 5.8% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 107,065 shares of the conglomerate’s stock after selling 6,532 shares during the period. Danaher makes up approximately 2.2% of Mar Vista Investment Partners LLC’s portfolio, making the stock its 20th largest position. Mar Vista Investment Partners LLC’s holdings in Danaher were worth $24,509,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of the business. JPL Wealth Management LLC acquired a new stake in shares of Danaher during the third quarter valued at about $25,000. Elevated Capital Advisors LLC purchased a new stake in shares of Danaher during the fourth quarter worth $26,000. WFA of San Diego LLC acquired a new stake in Danaher in the 2nd quarter valued at about $26,000. ANTIPODES PARTNERS Ltd acquired a new stake in Danaher in the third quarter valued at approximately $27,000. Finally, Hilton Head Capital Partners LLC acquired a new stake in shares of Danaher in the 4th quarter valued at $27,000. 79.05% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on DHR shares. Guggenheim decreased their target price on Danaher from $275.00 to $235.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Royal Bank Of Canada started coverage on shares of Danaher in a research note on Thursday, May 14th. They set an “outperform” rating and a $200.00 target price for the company. Citigroup began coverage on shares of Danaher in a research report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price objective on the stock. DZ Bank initiated coverage on Danaher in a report on Wednesday, June 3rd. They issued a “buy” rating and a $210.00 price objective on the stock. Finally, UBS Group dropped their target price on shares of Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a report on Wednesday, April 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company. According to MarketBeat.com, Danaher has a consensus rating of “Moderate Buy” and a consensus target price of $233.61.

Danaher Stock Performance

NYSE:DHR opened at $181.57 on Wednesday. The firm’s 50 day moving average is $180.54 and its two-hundred day moving average is $203.94. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The company has a market cap of $128.51 billion, a P/E ratio of 35.12, a P/E/G ratio of 2.31 and a beta of 0.81.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 EPS for the quarter, topping the consensus estimate of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The company had revenue of $5.95 billion during the quarter, compared to analyst estimates of $6 billion. During the same period in the prior year, the firm posted $1.88 earnings per share. The firm’s revenue was up 3.7% on a year-over-year basis. Analysts expect that Danaher Corporation will post 8.45 EPS for the current year.

Danaher Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a $0.40 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $1.60 annualized dividend and a dividend yield of 0.9%. Danaher’s dividend payout ratio is presently 30.95%.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.